We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Biomarker Test to Improve Endometrial Cancer Diagnosis

By LabMedica International staff writers
Posted on 25 Mar 2024
Print article
Image: A kinder test could improve diagnosis of womb cancer (Photo courtesy of crytal light/Shutterstock)
Image: A kinder test could improve diagnosis of womb cancer (Photo courtesy of crytal light/Shutterstock)

Womb cancer, a common cancer in women, is mainly characterized by abnormal bleeding, especially after menopause. While only a small fraction, 5-10%, of women experiencing such bleeding are diagnosed with womb cancer, various benign conditions like polyps and fibroids can also cause bleeding. Presently, women suspected of having womb cancer undergo a transvaginal ultrasound scan, which involves inserting a probe into the vagina to check the thickness of the womb's lining. If the lining appears thickened, further examination is done through hysteroscopy, a process where a narrow telescope equipped with a camera and light is introduced into the womb via the vagina and cervix, and sometimes a biopsy is conducted. These procedures, though thorough, are invasive and often cause discomfort, generating unnecessary stress for the majority of women who do not have the condition. Now, a simple, safe, and accurate test that identifies women with womb cancer from a sample taken from the vagina could spare many healthy women from unnecessary invasive tests.

Clinician scientists from the University of Manchester (Manchester, UK) have discovered a panel of five protein markers in vaginal fluid that can accurately differentiate women with womb cancer from those without the disease. This advancement has led to the development of a test boasting over 95% accuracy in identifying post-menopausal women whose bleeding stems from cancer, surpassing the accuracy of existing diagnostic methods. The new test raises hopes for enhancing womb cancer diagnosis and reducing reliance on the current, more invasive, and anxiety-inducing hospital procedures like hysteroscopy.

During the study, samples were collected from post-menopausal women presenting symptoms, including 53 diagnosed with endometrial cancer and 65 without. The research utilized SWATH-MS, an advanced mass spectrometry technique that calculates molecular masses to reveal their composition and structure. This approach allowed for the meticulous analysis of molecules and the creation of digital protein maps from the samples. Utilizing machine learning, the researchers identified the proteins that differed significantly between the samples, leading to the development of a simple and highly accurate diagnostic model based on proteins. Going forward, the team aims to develop clinically viable tests employing well-established methods such as ELISA or Lumipulse®, or potentially exploring new platforms like lateral flow tests for rapid point-of-care testing.

“The implications of this study are significant,” said Dr Kelechi Njoku from the from University of Manchester who led the study. “If translated into clinical practice, a non-invasive, cost-effective, and accurate detection tool could improve patient care by swiftly identifying those with womb cancer while sparing many healthy women from unnecessary invasive tests.”

Related Links:
University of Manchester

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.